William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session.
William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session.
William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session.
Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks.
Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks.
Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks.
Ronald Martin, from the North Carolina Harm Reduction Coalition, outlines the challenges associated with implementing a harm reduction model to combat the opioid crisis, as well as ways to overcome these...
